Based on Fortune Business Insights’ report, the U.S. diabetes drugs market share sector attained a worth of USD 30.47 billion in 2022. Forecasts indicate a promising path ahead, foreseeing a Compound Annual Growth Rate (CAGR) of 7.6% from 2022 to 2030. This trajectory will culminate in a noteworthy achievement of by 2030, highlighting considerable opportunities within this flourishing high-volume […]
Tag: U.S. Diabetes Drugs Market
Back To Top